AmBev Agrees to Merge with Interbrew

Genzyme bids for certain assets of bankrupt outfit Impath, and more deal news

Brazil's Companhia de Bebidas das Americas (known as AmBev) (ABV ) and Belgium's Interbrew agreed to merge in an $11.2 billion deal. The combined InterbrewAmBev would command 14% of the global beer market. Terms: Interbrew will hold 21.8% economic interest in AmBev and 52.8% voting interest; AmBev will acquire Interbrew's Labatt unit. (3/3)

Genzyme Corp. (GENZ ) says it signed a definitive agreement to become the "stalking horse" in the auction to acquire certain assets of bankrupt outfit Impath -- namely its physician services unit which provides oncology testing -- for $215 million in cash. (3/1)

Genzyme Corp. (GENZ ) agrees to acquire Ilex Oncology (ILXO ) for $26 per share in GENZ stock. (2/26)

Silver Acquisition Corp. agrees to buy Gold Banc (GLDB ) for $16.60 per share. (2/25)

Jones Apparel Group (JNY ) makes an unsolicited bid for Maxwell Shoe (MAXS ) of $20 per share. (2/25)

Golden State Vintners (VINT ) gets two bids, including one bid from a group of existing holders that includes CEO Jeffrey B. O'Neill. It did not disclose terms. (2/24)

Synopsys (SNPS ) agrees to buy Monolithic System Technology (MOSY ) for $13.50 per share in cash and stock. (2/24)

Clinical Data (CLDA ) offers to buy Moore Medical (MMD ). Terms: 0.698 CLDA share for each MMD share. (2/24)

Before it's here, it's on the Bloomberg Terminal. LEARN MORE